TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Desitin Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
8,016
|
10,905
|
12,009 |
Financial expenses |
0
|
40
|
59 |
Earnings before taxes |
803
|
1,332
|
1,595 |
EBITDA |
802
|
1,372
|
1,655 |
Total assets |
9,035
|
5,602
|
6,353 |
Current assets |
9,035
|
5,602
|
6,353 |
Current liabilities |
4,713
|
1,173
|
1,435 |
Equity capital |
4,322
|
4,429
|
3,825 |
- share capital |
98
|
96
|
100 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
47.8%
|
79.1%
|
60.2% |
Turnover per employee |
4,008
|
3,635
|
4,003 |
Profit as a percentage of turnover |
10.0%
|
12.2%
|
13.3% |
Return on assets (ROA) |
8.9%
|
24.5%
|
26.0% |
Current ratio |
191.7%
|
477.6%
|
442.7% |
Return on equity (ROE) |
18.6%
|
30.1%
|
41.7% |
Change turnover |
-3,133
|
-618
|
2,824 |
Change turnover % |
-28%
|
-5%
|
31% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.